Dissociating HDL cholesterol from cardiovascular risk

被引：3

作者：

Hausenloy, Derek J. ^{[1
]}

Opie, Lionel ^{[2
]}

Yellon, Derek M. ^{[1
]}

机构：

[1] Univ Coll London Hosp, Hatter Cardiovasc Inst, London WC1E 6HX, England

[2] Univ Cape Town, Dept Med, Hatter Cardiovasc Res Inst, ZA-7700 Rondebosch, South Africa

来源：

LANCET | 2010年 / 376卷 / 9738期

关键词：

HIGH-DENSITY-LIPOPROTEIN; ACUTE CORONARY SYNDROMES; DISEASE; THERAPY; STATINS; EVENTS; MEN;

D O I：

10.1016/S0140-6736(10)61021-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：305 / 306

页数：2

共 13 条

[1] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[2] HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events [J].

Barter, Philip ;

Gotto, Antonio M. ;

LaRosa, John C. ;

Maroni, Jaman ;

Szarek, Michael ;

Grundy, Scott M. ;

Kastelein, John J. P. ;

Bittner, Vera ;

Fruchart, Jean-Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13) :1301-1310

[3] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[4] Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol [J].

deGoma, Emil M. ;

Leeper, Nicholas J. ;

Heidenreich, Paul A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) :49-55

[5] Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality - A 21-year follow-up of 8000 men [J].

Goldbourt, U ;

Yaari, S ;

Medalie, JH .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :107-113

[6] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND CARDIOVASCULAR-DISEASE - 4 PROSPECTIVE AMERICAN-STUDIES [J].

GORDON, DJ ;

PROBSTFIELD, JL ;

GARRISON, RJ ;

NEATON, JD ;

CASTELLI, WP ;

KNOKE, JD ;

JACOBS, DR ;

BANGDIWALA, S ;

TYROLER, HA .

CIRCULATION, 1989, 79 (01) :8-15

[7]

Grover SA, 2009, ARCH INTERN MED, V169, P1775, DOI 10.1001/archinternmed.2009.328

[8] Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels [J].

Hausenloy, Derek J. ;

Yellon, Derek M. .

CURRENT OPINION IN CARDIOLOGY, 2009, 24 (05) :473-482

[9] Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].

LaRosa, JC ;

Grundy, SM ;

Waters, DD ;

Shear, C ;

Barter, P ;

Fruchart, J ;

Gotto, AM ;

Greten, H ;

Kastelein, JJP ;

Shepherd, J ;

Wenger, NK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435

[10] High-Density Lipoprotein and Coronary Heart Disease Current and Future Therapies [J].

Natarajan, Pradeep ;

Ray, Kausik K. ;

Cannon, Christopher P. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (13) :1283-1299

← 1 2 →